VISIE Inc.
- Industry
- Medical Devices & Equipment
- Founded Year
- 2017
- Headquarters
- Austin, Texas, United States
- Employee Count
- 10
Key People
- Jeff Levine - Chief Executive Officer, Co-Founder
- Aaron Bernstein - Chief Technology Officer, Co-Founder
- Rey Madolora - Chief Financial Officer
- Klaudius Scheufele - Vice President, Algorithmic Development and Data Science
- Tony Wonsyld - Director of Software Engineering
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises experienced professionals with significant industry expertise.
The leadership team includes individuals with over a decade of experience in the medical device industry, enhancing the company's credibility and operational effectiveness.
- Clinical Need
-
Aspect: Very Strong
Summary: The company's technology addresses a critical need for real-time, accurate intra-operative imaging.
By providing real-time, high-accuracy 3D surface mapping, the company's technology aims to reduce surgical errors and improve patient outcomes, addressing a pressing need in the medical field.
- Competition
-
Aspect: First mover
Summary: The company is among the first to offer real-time, contactless 3D surface mapping in surgery.
The company's innovative approach positions it ahead of competitors, allowing it to establish a strong market presence before others enter the space.
- Technical Challenge
-
Aspect: Complex
Summary: Developing real-time, high-accuracy 3D imaging technology presents significant technical challenges.
The complexity of creating accurate, real-time imaging systems requires advanced engineering and significant R&D investment, posing potential hurdles to timely product development.
- Patent
-
Aspect: Very Strong
Summary: The company holds nine U.S. and international patents on its optical scanning technology.
The extensive patent portfolio provides a competitive advantage by protecting the company's innovative technology from replication by competitors.
- Financing
-
Aspect: Well-funded
Summary: The company has raised $8.2M in an oversubscribed Series A funding round.
The successful funding round indicates investor confidence and provides the necessary resources for product development, regulatory approval, and commercialization efforts.
- Regulatory
-
Aspect: Running FIH
Summary: The company is conducting a clinical spine study with a teaching hospital.
Engaging in first-in-human (FIH) trials demonstrates the company's commitment to validating its technology and is a critical milestone in the regulatory approval process.
Opportunity Rollup
- Odds of Success
- 4.1
- Peak Market Share
- 6
- Segment CAGR
- 3.0%
- Market Segment
- Orthopedic Devices
- Market Sub Segment
- Surgical Navigation Systems
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.30 |
| 2 | 0.90 |
| 3 | 2.10 |
| 4 | 4.20 |
| 5 | 6.00 |
Key Takeaway
VISIE Inc. is well-positioned to capitalize on the growing demand for precision surgical technologies, supported by a strong team, innovative product, and solid financial backing.